EBV/host synthetic lethal screens to identify therapeutic targets for multiple sclerosis
Genome-wide CRISPR/Cas9 screens to discover host gene vulnerabilities in B cells latently infected with Epstein-Barr Virus (EBV), enabling targeted depletion of EBV-infected B cells for multiple sclerosis (MS) treatment....